News

Researchers discovered that combining stress management with nutrition education improves parenting behaviors and reduces childhood obesity rates.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

New research demonstrates that moderate to high exercise levels before and during pregnancy can significantly enhance early childhood neurodevelopmental.

New data reveal that implementing rapid diagnostic testing for RSV reduces the rate of unnecessary antibiotic prescriptions for viral respiratory infections.

Clesrovimab has been shown to maintain RSV-protection in infants across 2 RSV seasons, while also having positive safety data.

Clinical trial data demonstrate that clesrovimab maintains a safety profile comparable to palivizumab while providing significant protection against RSV-related infections.

Two recent studies offer insights into the success of nonoperative treatments for pediatric spondylolysis and the potential fracture risks linked to growth hormone therapy.

A study found that drying very preterm infants before immediate plastic wrapping offers no improvement in temperature regulation.

A study found that delivering a small dose of sucrose before painful hospital procedures offers simple and rapid pain reduction for newborns.

A study found no significant difference in increased intracranial pressure risk between surgical and conservative management for children with metopic synostosis.

Wright joins Schroer for a discussion on updates in pediatric eosinophilic esophagitis at AAAAI 2026.

New data reveal who misses oral food challenges despite scheduling, spotlighting race and insurance gaps—and the barriers clinics can fix.

The expanded approval provides young pediatric patients with a proven, effective treatment to significantly reduce dangerously high LDL-C levels.

Brian Schroer, MD, highlights recent data exploring the origins of EoE inflammation and the efficacy and limitations of recent biologic treatments.

UCB leadership discusses how bridging regulatory approval and real-world access requires integrated care coordination and a long-term commitment to the patient journey.

Carissa Baker-Smith, MD, MPH, outlines practical office-based interventions to help pediatricians effectively manage youth cardiovascular risk factors.

The approval offers a new genotype-independent treatment option for patients aged 12 years and older, significantly reducing blood phenylalanine levels.

Carissa M. Baker-Smithm MD, MPH, outlines how pediatricians can mitigate long-term cardiovascular risk.

Hao Zhang, PhD, MPH, and Biaskha “Pia” Sen, PHD, discuss factors contributing to the rise in pediatric diabetes rates.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

David Fleischer, MD, discusses how the VITESSE trial positions the VIASKIN peanut patch as a promising option for children with peanut allergy.

Early identification of X-linked hypophosphatemia can prevent long-term skeletal deformities and improve outcomes through timely initiation of targeted therapy.

FDA okays once-weekly navepegritide for children with achondroplasia, boosting growth with strong trial data; rollout expected early Q2 2026.

The FDA has approved once-weekly somapacitan-beco for children aged 2.5 years and older with 3 separate growth indications.

A study found that hepatitis B virus birth dose vaccination rates fell from 83.5% in early 2023 to 73.2% by August 2025.

Druhan L. Howell, MD, discusses how new data on once-daily tapinarof show early, sustained improvements in itch and sleep outcomes.

A study found that cannabis use was associated with a doubled risk of psychotic and bipolar disorders.

The FDA has approved desmopressin acetate, the first formulation designed for individualized dosing in patients with central diabetes insipidus.